Does PEMBROLIZUMAB Cause Autoimmune hepatitis? 315 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 315 reports of Autoimmune hepatitis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.4% of all adverse event reports for PEMBROLIZUMAB.
315
Reports of Autoimmune hepatitis with PEMBROLIZUMAB
0.4%
of all PEMBROLIZUMAB reports
76
Deaths
165
Hospitalizations
How Dangerous Is Autoimmune hepatitis From PEMBROLIZUMAB?
Of the 315 reports, 76 (24.1%) resulted in death, 165 (52.4%) required hospitalization, and 48 (15.2%) were considered life-threatening.
Is Autoimmune hepatitis Listed in the Official Label?
Yes, Autoimmune hepatitis is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Autoimmune hepatitis?
NIVOLUMAB (481)
ATORVASTATIN (357)
IPILIMUMAB (352)
ADALIMUMAB (237)
INFLIXIMAB (191)
ATEZOLIZUMAB (146)
METHOTREXATE (146)
NITROFURANTOIN (130)
PREDNISONE (107)
CARBOPLATIN (104)
Which PEMBROLIZUMAB Alternatives Have Lower Autoimmune hepatitis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G